Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Regional airports like Palm Springs International Airlines are trying to expand international offerings after traffic ...

On Thursday, former Vice President Kamala Harris toured the Palisades fire zone with Supervisor Lindsay Horvath, while EPA ...

Beaver Stadium looks drastically different, as the West side's press box and upper seating deck have been removed.

President Donald Trump has begun his second administration with a series of controversial moves and decisions.

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

Kura and Kyowa used the announcement to confirm that they are on track to file a new drug approval application with the FDA ...

Jasper’s Downtown Revitalization Phase II Project is moving forward despite recent setbacks caused by last month’s ice storm, according to city officials. Construction teams are working to compensate ...

And with a growing number of companies in the GLP-1 space, investors may be losing interest in the stock. Could Viking's ...